Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study
临床试验中心招募的晚期实体瘤患者中抗PD-1/PD-L1疗法的活性和疗效决定因素：一项基于生物标志物的前瞻性纵向研究
期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-022-03360-9
García-Corbacho, Javier; Indacochea, Alberto; González Navarro, Azucena E; Victoria, Iván; Moreno, Débora; Pesántez, David; Angelats, Laura; Modrego-Sanchez, Andrea; Sanfeliu, Esther; Castillo, Oleguer; Blasco, Paula; Mezquita, Laura; Viñolas, Nuria; Nogué, Miquel; Galván, Patricia; Adamo, Barbara; Basté, Neus; Sauri, Tamara; Juan, Manel; Prat, Aleix; Schettini, Francesco
